Skip to main content
Hit enter to search or ESC to close
Close Search
SeptiCyte™
Menu
  • HOME
  • TECHNOLOGY
  • PLATFORM
  • REFERENCES
  • ACADEMY
  • ADVOCACY
  • CONTACT US
Category

Uncategorized

Recent Posts

  • A Fully Integrated Diagnostic Test to Discriminate Sepsis from Infection-Negative Systemic Inflammation
  • A commercial rapid host-response test in COVID-19 severity stratification and triage

Recent Comments

    Archives

    • June 2022

    Categories

    • CLINICAL PUBLICATIONS
    • POSTERS

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • HOME
    • TECHNOLOGY
    • PLATFORM
    • REFERENCES
    • ACADEMY
    • ADVOCACY
    • CONTACT US

    SeptiCyte® RAPID is a CE marked IVD within the EU, and has 510(k) clearance in the U.S.

    Immunexpress is using the Idylla™ trademark under license from Biocartis.

    © 2020 SeptiCyte — All Rights Reserved.
    425 Pontius Avenue North, Suite 470
    Seattle, WA 98109 USA
    +1 206.858.6436
    clinical@septicyte.com

    Close Menu
    • HOME
    • TECHNOLOGY
    • PLATFORM
    • REFERENCES
    • ACADEMY
    • ADVOCACY
    • CONTACT US